Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Governors Form Health Reform Task Force: Will States Have To Trade Off Oversight For Coverage?

This article was originally published in The Pink Sheet Daily

Executive Summary

Michigan Gov. Granholm and Vermont Gov. Douglas will head the new task force.

You may also be interested in...



How Much Reform And How Fast? Key Questions For Presidential Address

Balance between push to expand coverage and restrain spending will be key for biopharma industry in analyzing Obama address Tuesday night. Here is a list of items to listen for.

Top Seven Pink Sheet Infographics Of 2023

A visual perspective on key regulatory topics in 2023, from clinical trial diversity to product approval trends and Medicare drug price negotiation.

Pink Sheet’s Top Seven Infographics Of 2022

From US drug pricing to Japan’s Sakigake expedited pathway, important regulatory developments and trends are easier to understand and track with Pink Sheet graphics.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069032

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel